English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Results: The pre-injection median VAS score was 9.00±0.61 with no difference between the two groups. On post-injection day 1, no difference was found in the median VAS scores between the two groups, although significant intergroup differences appeared at 1 and 6 months. Seven patients with VAS scores ≥5 in the follow-up were given additional injections. Four patients whose pain was not relieved after three injections underwent evisceration after 6 months. The median VAS scores were significantly lower in all patients at 12 months compared with the baseline. No difference was observed in the median VAS scores between the groups at the final follow-up. Complications included ptosis in five eyes and severe conjunctival chemosis in nine eyes.

Pain Management by Retrobulbar Alcohol Injection in Blind Painful Eyes Due to Late-Stage Neovascular Glaucoma